Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma

Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma

Abstract Background Hepatoma arterial-embolization prognostic (HAP) score and its modifications (modified HAP [mHAP] and mHAP-II), consisting of some or all of the following factors of tumor size, number, alpha-fetoprotein, bilirubin, and serum albumin, have been found to predict outcomes after tran...

Full description

Bibliographic Details
Main Authors: Yehyun Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jong Eun Yeon, Kwan Soo Byun, Hye Soo Kim, Ji Hoon Kim, Seung Up Kim
Format: Article
Language:English
Published: BMC 2019-04-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma
Trans-arterial chemoembolization
Risk prediction
Hepatoma arterial-embolization prognostic score
Online Access:http://link.springer.com/article/10.1186/s12885-019-5495-6

Internet

http://link.springer.com/article/10.1186/s12885-019-5495-6

Similar Items